Health Economics: Milrinone use in patient enrolled in hospice care

Health Economics: Milrinone use in patient enrolled in hospice care

Milrinone is a medication that is used to treatment patient with CHF. It is an expensive medication There is an ethical debate about the use in patient who are already in hospice care; (1) is it worth spending tax payers money(medicare) on expensive medication for pt(hospice) who have prognosis of less than 6 months (2)is it okay to deny patient(hospice pt) care they need because of money. I have an attachment with the rubric and an example of the presentation. I choose this topic because I work part time as a hospice nurse and I see management struggle with allowing Milrinone use or not, depending on pt insurance and other factors. I want a power point with note for each slide Let me know if you have any question. we can always make adjustment if you think there is not enough information on this topic, let me know if you have another current event that you think can work better with the economic aspect.